
Palatine-backed Vernacare refinances
Palatine Private Equity portfolio company Vernacare has completed a refinancing of its banking facilities.
Vernacare has repaid existing debt facilities provided by Tosca Debt Capital. New facilities have been provided by Pemberton Capital Advisors, with HSBC continuing to provide working capital facilities and everyday banking.
The refinancing will allow Palatine to return capital to its investors.
Vernacare, which is a Palatine Equity Fund III portfolio company, will continue to pursue a buy-and-build strategy.
Previous funding
In 2015, Palatine backed the management buyout of the company, drawing equity from its Palatine Private Equity Fund III. The fund closed on £220m in 2015.
The company acquired HCS in 2017.
Company
Headquartered in Chorley and with manufacturing facilities in Bolton, Vernacare produces medical products such as a single-use infection-control toileting system. Founded in 1964, the company employs 260 people.
People
Palatine Private Equity – Andy Lees (partner).
Vernacare – Matt Miller (CEO).
Advisers
Equity – Clearwater International (corporate finance); DLA Piper (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater